S&P futures are down 0.1% Wednesday morning, near session lows, following Tuesday’s decline where the S&P and Nasdaq both fell over 1% in their worst session since December 18. Asian markets were mostly weaker overnight, with Hong Kong lagging, while Australia and South Korea posted gains. European markets are up ~0.2%. Treasuries are weaker with […]
ETFsector.com Daily Trading Outlook, January 8, 2025 Read More »
The main indexes on Wall Street finished Monday’s trading session with mixed results. The only index that decreased was the Dow Jones Industrial Average, which fell by 0.06 percent or 25.57 points to end the day at 42,706.56.
Investor enthusiasm leads to the rise of these 10 stocks. Read More »
nVerses Capital LLC bought a new position in Inari Medical, Inc. (NASDAQ:NARI) in the second quarter, according to its latest 13F filing with the Securities and Exchange Commission.
The Rosen Law Firm, an international law firm representing investor rights, is reminding buyers of Inari Medical, Inc. common stock about a specific period of stock purchases.
Contact Hagens Berman before the July 12, 2024 deadline to participate in the class action lawsuit against Inari Medical (NARI).
Law Offices of Howard G. Smith is reminding investors that class action lawsuits have been filed on behalf of shareholders of certain companies.
Former Louisiana Attorney General reminds investors who have lost more than $100,000 about the deadline for lead plaintiff in the class action lawsuit against Inari Medical.
NARI investors can take the lead in the securities fraud lawsuit against Inari Medical, Inc.
The law firm Rosen Law Firm is reminding buyers of Inari Medical, Inc. common stock purchased between February 24 that they have investor rights.
Hagens Berman is encouraging investors who have suffered significant losses in Inari Medical, Inc. (NASDAQ: NARI) to reach out to the firm.
Stay updated with the latests analysis and insights fromm etfsector.com
